Article
Druggable genome and precision medicine in cancer: current challenges
24 Feb 2021
Abstract excerpt
The past decades have seen tremendous developments with respect to "specific" therapeutics that target key signaling molecules to conquer cancer. The key advancements with multiomics technologies, especially genomics, have allowed physicians and molecular oncologists to design "tailor-made" solutions to the specific oncogenes that are deregulated in individual patients, a strategy which has turned out to be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
